Literature DB >> 20189471

The importance of XRCC2 in RAD51-related DNA damage repair.

Cathryn E Tambini1, Karen G Spink, Caroline J Ross, Mark A Hill, John Thacker.   

Abstract

The repair of DNA damage by homologous recombination (HR) is a key pathway for the maintenance of genetic stability in mammalian cells, especially during and following DNA replication. The central HR protein is RAD51, which ensures high fidelity DNA repair by facilitating strand exchange between damaged and undamaged homologous DNA segments. Several RAD51-like proteins, including XRCC2, appear to help with this process, but their roles are not well understood. Here we show that XRCC2 is highly conserved and that most substantial truncations of the protein destroy its ability to function. XRCC2 and its partner protein RAD51L3 are found to interact with RAD51 in the 2-hybrid system, and XRCC2 is shown to be important but not essential for the accumulation of RAD51 at the sites of DNA damage. We visualize the localization of XRCC2 protein at the same sites of DNA damage for the first time using specialized irradiation conditions. Our data indicate that an important function of XRCC2 is to enhance the activity of RAD51, so that the loss of XRCC2 results in a severe delay in the early response of RAD51 to DNA damage. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20189471     DOI: 10.1016/j.dnarep.2010.01.016

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  22 in total

1.  MiRNA-binding site functional polymorphisms in DNA repair genes RAD51, RAD52, and XRCC2 and breast cancer risk in Chinese population.

Authors:  Jingjing Cao; Chenglin Luo; Rui Peng; Qiaoyun Guo; Kaijuan Wang; Peng Wang; Hua Ye; Chunhua Song
Journal:  Tumour Biol       Date:  2016-10-10

2.  Association of reduced XRCC2 expression with lymph node metastasis in breast cancer tissues.

Authors:  Nabiha Bashir; Syeda Sana; Ishrat Mahjabeen; Mahmood Akhtar Kayani
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

3.  The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis.

Authors:  Shujing Shi; Lingyan Qin; Mengqiu Tian; Mao Xie; Xiaoxue Li; Chenglin Qi; Xiang Yi
Journal:  Tumour Biol       Date:  2014-03-06

4.  XRCC2 gene polymorphisms and its protein are associated with colorectal cancer susceptibility in Chinese Han population.

Authors:  Xia-Bin Li; Hua Luo; Juan Huang; Jie-Dong Zhang; Zi-Xi Yang; Xing-Wang Sun
Journal:  Med Oncol       Date:  2014-10-11       Impact factor: 3.064

5.  Analysis of XRCC2 and XRCC3 gene polymorphisms in pancreatic cancer.

Authors:  Renata Talar-Wojnarowska; Anita Gąsiorowska; Marek Olakowski; Daria Dranka-Bojarowska; Paweł Lampe; Beata Smolarz; Ewa Małecka-Panas
Journal:  Biomed Rep       Date:  2015-12-02

6.  Rare mutations in XRCC2 increase the risk of breast cancer.

Authors:  D J Park; F Lesueur; T Nguyen-Dumont; M Pertesi; F Odefrey; F Hammet; S L Neuhausen; E M John; I L Andrulis; M B Terry; M Daly; S Buys; F Le Calvez-Kelm; A Lonie; B J Pope; H Tsimiklis; C Voegele; F M Hilbers; N Hoogerbrugge; A Barroso; A Osorio; G G Giles; P Devilee; J Benitez; J L Hopper; S V Tavtigian; D E Goldgar; M C Southey
Journal:  Am J Hum Genet       Date:  2012-03-29       Impact factor: 11.025

7.  Resection activity of the Sgs1 helicase alters the affinity of DNA ends for homologous recombination proteins in Saccharomyces cerevisiae.

Authors:  Kara A Bernstein; Eleni P Mimitou; Michael J Mihalevic; Huan Chen; Ivana Sunjaveric; Lorraine S Symington; Rodney Rothstein
Journal:  Genetics       Date:  2013-10-04       Impact factor: 4.562

8.  Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy.

Authors:  Ming Yin; Zhongxing Liao; Yu-Jing Huang; Zhensheng Liu; Xianglin Yuan; Daniel Gomez; Li-E Wang; Qingyi Wei
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

9.  Repair of DNA strand breaks in a minichromosome in vivo: kinetics, modeling, and effects of inhibitors.

Authors:  Slawomir Kumala; Krzysztof Fujarewicz; Dheekollu Jayaraju; Joanna Rzeszowska-Wolny; Ronald Hancock
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

Review 10.  Hereditary breast cancer: the era of new susceptibility genes.

Authors:  Paraskevi Apostolou; Florentia Fostira
Journal:  Biomed Res Int       Date:  2013-03-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.